1. Alessandri-Haber N, Dina OA, Joseph EK, Reichling D, Levine JD. (2006) A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators.
J. Neurosci., 26 (14): 3864-74.
[PMID:16597741]
2. Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, Levine JD. (2003) Hypotonicity induces TRPV4-mediated nociception in rat.
Neuron, 39 (3): 497-511.
[PMID:12895423]
3. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI. (2006) Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury.
Circ. Res., 99 (9): 988-95.
[PMID:17008604]
4. Auer-Grumbach M, Olschewski A, Papić L, Kremer H, McEntagart ME, Uhrig S, Fischer C, Fröhlich E, Bálint Z, Tang B et al.. (2010) Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.
Nat. Genet., 42 (2): 160-4.
[PMID:20037588]
5. Benfenati V, Amiry-Moghaddam M, Caprini M, Mylonakou MN, Rapisarda C, Ottersen OP, Ferroni S. (2007) Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes.
Neuroscience, 148 (4): 876-92.
[PMID:17719182]
6. Birder L, Kullmann FA, Lee H, Barrick S, de Groat W, Kanai A, Caterina M. (2007) Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat.
J. Pharmacol. Exp. Ther., 323 (1): 227-35.
[PMID:17636010]
7. Camacho N, Krakow D, Johnykutty S, Katzman PJ, Pepkowitz S, Vriens J, Nilius B, Boyce BF, Cohn DH. (2010) Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.
Am. J. Med. Genet. A, 152A (5): 1169-77.
[PMID:20425821]
8. Cuajungco MP, Grimm C, Oshima K, D'hoedt D, Nilius B, Mensenkamp AR, Bindels RJ, Plomann M, Heller S. (2006) PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4.
J. Biol. Chem., 281 (27): 18753-62.
[PMID:16627472]
9. Delany NS, Hurle M, Facer P, Alnadaf T, Plumpton C, Kinghorn I, See CG, Costigan M, Anand P, Woolf CJ et al.. (2001) Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2.
Physiol. Genomics, 4 (3): 165-74.
[PMID:11160995]
10. Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, Yau HJ, Yang Y, Zhai H, Siddique N et al.. (2010) Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.
Nat. Genet., 42 (2): 165-9.
[PMID:20037587]
11. Deng Z, Paknejad N, Maksaev G, Sala-Rabanal M, Nichols CG, Hite RK, Yuan P. (2018) Cryo-EM and X-ray structures of TRPV4 reveal insight into ion permeation and gating mechanisms.
Nat. Struct. Mol. Biol., 25 (3): 252-260.
[PMID:29483651]
12. Dunn KM, Hill-Eubanks DC, Liedtke WB, Nelson MT. (2013) TRPV4 channels stimulate Ca2+-induced Ca2+ release in astrocytic endfeet and amplify neurovascular coupling responses.
Proc. Natl. Acad. Sci. U.S.A., 110 (15): 6157-62.
[PMID:23530219]
13. Earley S, Pauyo T, Drapp R, Tavares MJ, Liedtke W, Brayden JE. (2009) TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure.
Am. J. Physiol. Heart Circ. Physiol., 297 (3): H1096-102.
[PMID:19617407]
14. Everaerts W, Vriens J, Owsianik G, Appendino G, Voets T, De Ridder D, Nilius B. (2010) Functional characterization of transient receptor potential channels in mouse urothelial cells.
Am. J. Physiol. Renal Physiol., 298 (3): F692-701.
[PMID:20015940]
15. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, Hayward NJ, McNamara CR, Xue F, Moran MM et al.. (2010) Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.
Proc. Natl. Acad. Sci. U.S.A., 107 (44): 19084-9.
[PMID:20956320]
16. Galizia L, Pizzoni A, Fernandez J, Rivarola V, Capurro C, Ford P. (2012) Functional interaction between AQP2 and TRPV4 in renal cells.
J. Cell. Biochem., 113 (2): 580-9.
[PMID:21938744]
17. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, Owsianik G, Liedtke W, Daelemans D, Dewachter I et al.. (2007) Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding.
J. Clin. Invest., 117 (11): 3453-62.
[PMID:17948126]
18. Gradilone SA, Masyuk AI, Splinter PL, Banales JM, Huang BQ, Tietz PS, Masyuk TV, Larusso NF. (2007) Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion.
Proc. Natl. Acad. Sci. U.S.A., 104 (48): 19138-43.
[PMID:18024594]
19. Guler AD, Lee H, Iida T, Shimizu I, Tominaga M, Caterina M. (2002) Heat-evoked activation of the ion channel, TRPV4.
J. Neurosci., 22 (15): 6408-14.
[PMID:12151520]
20. Hamanaka K, Jian MY, Weber DS, Alvarez DF, Townsley MI, Al-Mehdi AB, King JA, Liedtke W, Parker JC. (2007) TRPV4 initiates the acute calcium-dependent permeability increase during ventilator-induced lung injury in isolated mouse lungs.
Am. J. Physiol. Lung Cell Mol. Physiol., 293 (4): L923-32.
[PMID:17660328]
21. Klausen TK, Pagani A, Minassi A, Ech-Chahad A, Prenen J, Owsianik G, Hoffmann EK, Pedersen SF, Appendino G, Nilius B. (2009) Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study.
J. Med. Chem., 52 (9): 2933-9.
[PMID:19361196]
22. Krakow D, Vriens J, Camacho N, Luong P, Deixler H, Funari TL, Bacino CA, Irons MB, Holm IA, Sadler L et al.. (2009) Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.
Am. J. Hum. Genet., 84 (3): 307-15.
[PMID:19232556]
23. Kusudo T, Wang Z, Mizuno A, Suzuki M, Yamashita H. (2012) TRPV4 deficiency increases skeletal muscle metabolic capacity and resistance against diet-induced obesity.
J. Appl. Physiol., 112 (7): 1223-32.
[PMID:22207724]
24. Lamandé SR, Yuan Y, Gresshoff IL, Rowley L, Belluoccio D, Kaluarachchi K, Little CB, Botzenhart E, Zerres K, Amor DJ et al.. (2011) Mutations in TRPV4 cause an inherited arthropathy of hands and feet.
Nat. Genet., 43 (11): 1142-6.
[PMID:21964574]
25. Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, Shi Y, Taye AA, Kong L, Munns CH et al.. (2010) Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
Nat. Genet., 42 (2): 170-4.
[PMID:20037586]
26. Liedtke W, Choe Y, Martí-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. (2000) Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor.
Cell, 103 (3): 525-35.
[PMID:11081638]
27. Liu X, Bandyopadhyay BC, Bandyopadhyay B, Nakamoto T, Singh B, Liedtke W, Melvin JE, Ambudkar I. (2006) A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery.
J. Biol. Chem., 281 (22): 15485-95.
[PMID:16571723]
28. Ma X, Nilius B, Wong JW, Huang Y, Yao X. (2011) Electrophysiological properties of heteromeric TRPV4-C1 channels.
Biochim. Biophys. Acta, 1808 (12): 2789-97.
[PMID:21871867]
29. Ma X, Qiu S, Luo J, Ma Y, Ngai CY, Shen B, Wong CO, Huang Y, Yao X. (2010) Functional role of vanilloid transient receptor potential 4-canonical transient receptor potential 1 complex in flow-induced Ca2+ influx.
Arterioscler. Thromb. Vasc. Biol., 30 (4): 851-8.
[PMID:20093626]
30. Masuyama R, Vriens J, Voets T, Karashima Y, Owsianik G, Vennekens R, Lieben L, Torrekens S, Moermans K, Vanden Bosch A et al.. (2008) TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
Cell Metab., 8 (3): 257-65.
[PMID:18762026]
31. Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y et al.. (2008) Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss.
J. Cell. Physiol., 216 (1): 47-53.
[PMID:18264976]
32. Parenti A, De Logu F, Geppetti P, Benemei S. (2016) What is the evidence for the role of TRP channels in inflammatory and immune cells?.
Br. J. Pharmacol., 173 (6): 953-69.
[PMID:26603538]
33. Poole DP, Amadesi S, Veldhuis NA, Abogadie FC, Lieu T, Darby W, Liedtke W, Lew MJ, McIntyre P, Bunnett NW. (2013) Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.
J. Biol. Chem., 288 (8): 5790-802.
[PMID:23288842]
34. Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, Lachman RS, Wilcox WR, Reyno S, Quadrelli R et al.. (2008) Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
Nat. Genet., 40 (8): 999-1003.
[PMID:18587396]
35. Ryskamp DA, Witkovsky P, Barabas P, Huang W, Koehler C, Akimov NP, Lee SH, Chauhan S, Xing W, Rentería RC et al.. (2011) The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells.
J. Neurosci., 31 (19): 7089-101.
[PMID:21562271]
36. Sidhaye VK, Güler AD, Schweitzer KS, D'Alessio F, Caterina MJ, King LS. (2006) Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions.
Proc. Natl. Acad. Sci. U.S.A., 103 (12): 4747-52.
[PMID:16537379]
37. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE. (2006) Bisandrographolide from Andrographis paniculata activates TRPV4 channels.
J. Biol. Chem., 281 (40): 29897-904.
[PMID:16899456]
38. Sokabe T, Fukumi-Tominaga T, Yonemura S, Mizuno A, Tominaga M. (2010) The TRPV4 channel contributes to intercellular junction formation in keratinocytes.
J. Biol. Chem., 285 (24): 18749-58.
[PMID:20413591]
39. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD. (2000) OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.
Nat. Cell Biol., 2 (10): 695-702.
[PMID:11025659]
40. Strotmann R, Schultz G, Plant TD. (2003) Ca2+-dependent potentiation of the nonselective cation channel TRPV4 is mediated by a C-terminal calmodulin binding site.
J. Biol. Chem., 278 (29): 26541-9.
[PMID:12724311]
41. Suzuki M, Hirao A, Mizuno A. (2003) Microtubule-associated [corrected] protein 7 increases the membrane expression of transient receptor potential vanilloid 4 (TRPV4).
J. Biol. Chem., 278 (51): 51448-53.
[PMID:14517216]
42. Suzuki M, Mizuno A, Kodaira K, Imai M. (2003) Impaired pressure sensation in mice lacking TRPV4.
J. Biol. Chem., 278 (25): 22664-8.
[PMID:12692122]
43. Tabuchi K, Suzuki M, Mizuno A, Hara A. (2005) Hearing impairment in TRPV4 knockout mice.
Neurosci. Lett., 382 (3): 304-8.
[PMID:15925108]
44. Thorneloe KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian MY, Costell M, Maniscalco-Hauk K, Krawiec JA, Olzinski A et al.. (2012) An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.
Sci Transl Med, 4 (159): 159ra148.
[PMID:23136043]
45. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon E, Evans L et al.. (2008) N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
J. Pharmacol. Exp. Ther., 326 (2): 432-42.
[PMID:18499743]
46. Tian W, Fu Y, Garcia-Elias A, Fernández-Fernández JM, Vicente R, Kramer PL, Klein RF, Hitzemann R, Orwoll ES, Wilmot B et al.. (2009) A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.
Proc. Natl. Acad. Sci. U.S.A., 106 (33): 14034-9.
[PMID:19666518]
47. Todaka H, Taniguchi J, Satoh J, Mizuno A, Suzuki M. (2004) Warm temperature-sensitive transient receptor potential vanilloid 4 (TRPV4) plays an essential role in thermal hyperalgesia.
J. Biol. Chem., 279 (34): 35133-8.
[PMID:15187078]
48. Vincent F, Acevedo A, Nguyen MT, Dourado M, DeFalco J, Gustafson A, Spiro P, Emerling DE, Kelly MG, Duncton MA. (2009) Identification and characterization of novel TRPV4 modulators.
Biochem. Biophys. Res. Commun., 389 (3): 490-4.
[PMID:19737537]
49. Voets T, Prenen J, Vriens J, Watanabe H, Janssens A, Wissenbach U, Bödding M, Droogmans G, Nilius B. (2002) Molecular determinants of permeation through the cation channel TRPV4.
J. Biol. Chem., 277 (37): 33704-10.
[PMID:12093812]
50. Wang Y, Fu X, Gaiser S, Köttgen M, Kramer-Zucker A, Walz G, Wegierski T. (2007) OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum.
J. Biol. Chem., 282 (50): 36561-70.
[PMID:17932042]
51. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, Vriens J, Cairns W, Wissenbach U, Prenen J et al.. (2002) Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives.
J. Biol. Chem., 277 (16): 13569-77.
[PMID:11827975]
52. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.
Nature, 424 (6947): 434-8.
[PMID:12879072]
53. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. (2002) Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells.
J. Biol. Chem., 277 (49): 47044-51.
[PMID:12354759]
54. Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V et al.. (2015) Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.
Bioorg. Med. Chem. Lett., 25 (18): 4011-5.
[PMID:26235950]
55. Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, Turner GH, Ju H, Thomas H, Fishman CE et al.. (2008) Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.
J. Pharmacol. Exp. Ther., 326 (2): 443-52.
[PMID:18499744]
56. Wu L, Gao X, Brown RC, Heller S, O'Neil RG. (2007) Dual role of the TRPV4 channel as a sensor of flow and osmolality in renal epithelial cells.
Am. J. Physiol. Renal Physiol., 293 (5): F1699-713.
[PMID:17699550]
57. Xu F, Satoh E, Iijima T. (2003) Protein kinase C-mediated Ca2+ entry in HEK 293 cells transiently expressing human TRPV4.
Br. J. Pharmacol., 140 (2): 413-21.
[PMID:12970074]
58. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM. (2003) Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress.
J. Biol. Chem., 278 (13): 11520-7.
[PMID:12538589]
59. Ye L, Kleiner S, Wu J, Sah R, Gupta RK, Banks AS, Cohen P, Khandekar MJ, Boström P, Mepani RJ et al.. (2012) TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis.
Cell, 151 (1): 96-110.
[PMID:23021218]
60. Zaika O, Mamenko M, Berrout J, Boukelmoune N, O'Neil RG, Pochynyuk O. (2013) TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.
J. Am. Soc. Nephrol., 24 (4): 604-16.
[PMID:23411787]
61. Zhang DX, Mendoza SA, Bubolz AH, Mizuno A, Ge ZD, Li R, Warltier DC, Suzuki M, Gutterman DD. (2009) Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo.
Hypertension, 53 (3): 532-8.
[PMID:19188524]